On-Demand Webinars

31. The Role Of Developability In Lead Candidate Selection 6/12/2025

    Discover how developability assessments are crucial for identifying biologic candidates that are both effective and manufacturable, thereby reducing risks and improving the chances of clinical success.

32. Flexibility To Meet Your Process Needs 6/11/2025

    Explore a platform that adapts to your evolving workflow through real-world examples of how its flexibility supports diverse inputs, applications, and parameters to ensure consistency, scalability, and efficiency.

33. Prevent Batch Failures Before They Happen 6/11/2025

    Discover a platform that reduces operator errors and batch failures through automation, real-time monitoring, and intelligent design to ensure greater process reliability and consistent outcomes in your workflow.

34. Easy Integration Of A New Manufacturing Platform 6/11/2025

    Easily integrate an innovative platform into your manufacturing process with seamless onboarding, regulatory support, and expert guidance that is designed to help you confidently adopt good manufacturing practices.

35. Optimizing The Progression Of Biotherapeutic Candidates To FIH Studies 6/9/2025

    Learn actionable strategies that can lead to higher success rates and smarter resource investment, paving the way for a successful path to IND submissions and commercialization.

36. Simplify CAR-T Cell Manufacturing With LNP-Mediated Delivery 6/3/2025

    Streamline CAR-T cell manufacturing with lipid nanoparticles delivering base editors to create fratricide-resistant, CD45-edited CAR45 T cells, which enables scalable, precise, and potent therapies for blood cancers.

37. A New Look At Subcutaneous mAb Delivery Using Nanoformed Particles 6/3/2025

    A highly concentrated non-aqueous suspension of an IgG1 was developed using a patented platform. Review how the particle size of the mAb impacts the overall behavior of the drug product.

38. The Advantages Of Off-The-Shelf GMP iPSCs With A DMF 6/2/2025

    Learn how off-the-shelf, GMP-grade iPSC lines with a Drug Master File (DMF) can accelerate cell therapy development, streamline regulatory approval, and reduce time and cost to clinic.

39. Key Bioassay Strategies For Successful IND Submission 6/2/2025

    Watch Erika Kovacs, Senior Director of Bioassay, as she discusses critical considerations for developing stage-appropriate bioassays to support complex biologics and bioconjugates on the path to IND.

40. Advancements In Evaluating Fc-Mediated Functional Activity In Biologics 6/2/2025

    Watch this presentation to gain a comprehensive overview of how to evaluate Fc-mediated functions — and why doing so is vital to the success of biologic therapies.